⌘K

Home/Filings/4/0001062993-25-010697

4//SEC Filing

BAMFORD PASCAL 4

Accession 0001062993-25-010697

CIK 0001711933other

View on SEC.gov Company Profile

Filed

Jun 1, 8:00 PM ET

Accepted

Jun 2, 5:52 PM ET

Size

4.8 KB

Accession

0001062993-25-010697

Insider Transaction Report

Form 4

Period: 2025-06-01

Akoya Biosciences, Inc.AKYA

Chief Clinical Officer

Transactions

Tax Payment
Common Stock
2025-06-01$1.25/sh−670$838→ 205,738 total

Footnotes (1)

[F1]Represents shares withheld to cover taxes on a restricted stock unit award previously granted on May 18, 2023, which vests in four (4) annual equal installments beginning on June 1, 2024 and annually thereafter until fully vested.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

Akoya Biosciences, Inc.

CIK 0001711933

Entity typeother

Related Parties

1

filerCIK 0002035474

Filing Metadata

Form type: 4
Filed: Jun 1, 8:00 PM ET
Accepted: Jun 2, 5:52 PM ET
Size: 4.8 KB

View on SEC.gov